Novel markers in breast pathology

David J Dabbs; Richard S Huang; Jeffrey S Ross

doi:10.1111/his.14770

Novel markers in breast pathology

Histopathology. 2023 Jan;82(1):119-139. doi: 10.1111/his.14770. Epub 2022 Dec 5.

Authors

David J Dabbs^{1

2}, Richard S Huang³, Jeffrey S Ross⁴

Affiliations

¹ PreludeDx, Laguna Hills, CA, USA.
² Department of Pathology, University of Pittsburgh, Board Member, CASI (Consortium for Analytical Standardization in Immunohistochemistry), Pittsburgh, PA, USA.
³ Clinical Development, Foundation Medicine, Cambridge, MA, USA.
⁴ Foundation Medicine, Cambridge, MA, USA.

PMID: 36468266
DOI: 10.1111/his.14770

Abstract

Breast pathology is an ever-expanding database of information which includes markers, or biomarkers, that detect or help treat the disease as prognostic or predictive information. This review focuses on these aspects of biomarkers which are grounded in immunohistochemistry, liquid biopsies and next-generation sequencing.

Keywords: breast; immunohistochemistry; next generation sequencing; novel markers.

Publication types

Review